ALTAMIRA THERAPEUTICS LTD (CYTOF)
- Open
- 0.0641
- High
- 0.0641
- Low
- 0.0641
- Prev. Close
- 0.0641
- Volume
- 22
- Turnover
- 1.43
- Avg Price
- 0.0648
- Bid/Ask Ratio
- --
- Amplitude
- 0.00%
- 52wk High
- 0.1479
- Volume Ratio
- 0.03
- Turnover Ratio
- 0.00%
ALTAMIRA THERAPEUTICS LTD Analyst Rating
View moreForecast & Rating
Dec 27, 2024Price forecast
$5.318188.49%
Forecast & Rating-
0analysts
News
- TradingView · Apr 23 at 03:53 PM
Vax appoints James B. Breitmeyer to its Board
- businessinsider · Mar 28 at 08:57 AM
GLP-1 developer Kailera, proteomics firm Alamar file for U.S. IPOs
- RenaissanceCapital · Mar 27 at 05:24 PM
US Weekly Recap: Aerospace and healthcare issuers drive late-March filing activity
- Acceswire · Aug 29, 2025 at 06:30 AM
Altamira Therapeutics Provides Business Update and First Half 2025 Financial Results
- Acceswire · Aug 26, 2025 at 03:00 PM
Altamira Therapeutics to Host First Half 2025 Financial Results and Business Update Call on August 29, 2025
- GlobeNewswire · Jun 11, 2025 at 03:05 PM
Delisting of Securities of Blue Star Foods Corp.; Altamira Therapeutics Ltd.; Evergreen Corporation; Fresh2 Group Limited; Coliseum Acquisition Corp.; The Real Good Food Company, Inc.; Mynaric AG; byNordic Acquisition Corporation; Avinger Inc.; MultiMetaVerse Holdings Limited; Nature's Miracle Holding Inc.; and SPI Energy Co., Ltd. from the Nasdaq Stock Market
